IL6R and head and neck squamous cell carcinoma: Further, we showed that both genetic and pharmacologic inhibition of IL-6R signaling could suppress Cisplatin-mediated induction of the CSC fraction, Bmi-1 expression, and self-renewal of HNSCC cells.